nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Anaemia—Progesterone—uterine cancer	0.00461	0.00461	CcSEcCtD
Vancomycin—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00452	0.00452	CcSEcCtD
Vancomycin—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00452	0.00452	CcSEcCtD
Vancomycin—Vertigo—Progesterone—uterine cancer	0.00448	0.00448	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00447	0.00447	CcSEcCtD
Vancomycin—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00445	0.00445	CcSEcCtD
Vancomycin—Palpitations—Progesterone—uterine cancer	0.00441	0.00441	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Etoposide—uterine cancer	0.00438	0.00438	CcSEcCtD
Vancomycin—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00437	0.00437	CcSEcCtD
Vancomycin—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00434	0.00434	CcSEcCtD
Vancomycin—Fungal infection—Epirubicin—uterine cancer	0.00424	0.00424	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00422	0.00422	CcSEcCtD
Vancomycin—Agranulocytosis—Dactinomycin—uterine cancer	0.00421	0.00421	CcSEcCtD
Vancomycin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.00418	CcSEcCtD
Vancomycin—Necrosis—Epirubicin—uterine cancer	0.00417	0.00417	CcSEcCtD
Vancomycin—Anaphylactic shock—Progesterone—uterine cancer	0.00407	0.00407	CcSEcCtD
Vancomycin—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00406	0.00406	CcSEcCtD
Vancomycin—Infection—Progesterone—uterine cancer	0.00404	0.00404	CcSEcCtD
Vancomycin—Rigors—Epirubicin—uterine cancer	0.00401	0.00401	CcSEcCtD
Vancomycin—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00399	0.00399	CcSEcCtD
Vancomycin—Nervous system disorder—Progesterone—uterine cancer	0.00399	0.00399	CcSEcCtD
Vancomycin—Tachycardia—Progesterone—uterine cancer	0.00397	0.00397	CcSEcCtD
Vancomycin—Skin disorder—Progesterone—uterine cancer	0.00395	0.00395	CcSEcCtD
Vancomycin—Fungal infection—Doxorubicin—uterine cancer	0.00392	0.00392	CcSEcCtD
Vancomycin—Necrosis—Doxorubicin—uterine cancer	0.00386	0.00386	CcSEcCtD
Vancomycin—Erythema multiforme—Dactinomycin—uterine cancer	0.00383	0.00383	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00382	0.00382	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00381	0.00381	CcSEcCtD
Vancomycin—Hypotension—Progesterone—uterine cancer	0.0038	0.0038	CcSEcCtD
Vancomycin—Flushing—Dactinomycin—uterine cancer	0.00376	0.00376	CcSEcCtD
Vancomycin—Extravasation—Epirubicin—uterine cancer	0.00375	0.00375	CcSEcCtD
Vancomycin—Rigors—Doxorubicin—uterine cancer	0.00371	0.00371	CcSEcCtD
Vancomycin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00369	0.00369	CcSEcCtD
Vancomycin—Insomnia—Progesterone—uterine cancer	0.00368	0.00368	CcSEcCtD
Vancomycin—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00366	0.00366	CcSEcCtD
Vancomycin—Chills—Dactinomycin—uterine cancer	0.00363	0.00363	CcSEcCtD
Vancomycin—Dyspnoea—Progesterone—uterine cancer	0.00363	0.00363	CcSEcCtD
Vancomycin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00362	0.00362	CcSEcCtD
Vancomycin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00361	0.00361	CcSEcCtD
Vancomycin—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0036	0.0036	CcSEcCtD
Vancomycin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00358	CcSEcCtD
Vancomycin—Erythema—Dactinomycin—uterine cancer	0.00352	0.00352	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00351	0.00351	CcSEcCtD
Vancomycin—Fatigue—Progesterone—uterine cancer	0.00351	0.00351	CcSEcCtD
Vancomycin—Pain—Progesterone—uterine cancer	0.00348	0.00348	CcSEcCtD
Vancomycin—Constipation—Progesterone—uterine cancer	0.00348	0.00348	CcSEcCtD
Vancomycin—Extravasation—Doxorubicin—uterine cancer	0.00347	0.00347	CcSEcCtD
Vancomycin—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00345	0.00345	CcSEcCtD
Vancomycin—Creatinine increased—Epirubicin—uterine cancer	0.00344	0.00344	CcSEcCtD
Vancomycin—Neutropenia—Etoposide—uterine cancer	0.00342	0.00342	CcSEcCtD
Vancomycin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00334	0.00334	CcSEcCtD
Vancomycin—Gastrointestinal pain—Progesterone—uterine cancer	0.00333	0.00333	CcSEcCtD
Vancomycin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00329	0.00329	CcSEcCtD
Vancomycin—Infestation NOS—Etoposide—uterine cancer	0.00326	0.00326	CcSEcCtD
Vancomycin—Infestation—Etoposide—uterine cancer	0.00326	0.00326	CcSEcCtD
Vancomycin—Anaemia—Dactinomycin—uterine cancer	0.00326	0.00326	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00324	0.00324	CcSEcCtD
Vancomycin—Urticaria—Progesterone—uterine cancer	0.00323	0.00323	CcSEcCtD
Vancomycin—Abdominal pain—Progesterone—uterine cancer	0.00322	0.00322	CcSEcCtD
Vancomycin—Body temperature increased—Progesterone—uterine cancer	0.00322	0.00322	CcSEcCtD
Vancomycin—Renal failure—Etoposide—uterine cancer	0.00321	0.00321	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00318	0.00318	CcSEcCtD
Vancomycin—Creatinine increased—Doxorubicin—uterine cancer	0.00318	0.00318	CcSEcCtD
Vancomycin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00318	0.00318	CcSEcCtD
Vancomycin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00315	0.00315	CcSEcCtD
Vancomycin—Agranulocytosis—Etoposide—uterine cancer	0.00305	0.00305	CcSEcCtD
Vancomycin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00302	0.00302	CcSEcCtD
Vancomycin—Hypersensitivity—Progesterone—uterine cancer	0.003	0.003	CcSEcCtD
Vancomycin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.00293	CcSEcCtD
Vancomycin—Asthenia—Progesterone—uterine cancer	0.00292	0.00292	CcSEcCtD
Vancomycin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00292	0.00292	CcSEcCtD
Vancomycin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00292	0.00292	CcSEcCtD
Vancomycin—Pruritus—Progesterone—uterine cancer	0.00288	0.00288	CcSEcCtD
Vancomycin—Infection—Dactinomycin—uterine cancer	0.00286	0.00286	CcSEcCtD
Vancomycin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00282	0.00282	CcSEcCtD
Vancomycin—Erythema multiforme—Etoposide—uterine cancer	0.00277	0.00277	CcSEcCtD
Vancomycin—Phlebitis—Epirubicin—uterine cancer	0.00276	0.00276	CcSEcCtD
Vancomycin—Thrombophlebitis—Epirubicin—uterine cancer	0.00274	0.00274	CcSEcCtD
Vancomycin—Flushing—Etoposide—uterine cancer	0.00272	0.00272	CcSEcCtD
Vancomycin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00272	0.00272	CcSEcCtD
Vancomycin—Dizziness—Progesterone—uterine cancer	0.00269	0.00269	CcSEcCtD
Vancomycin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00265	CcSEcCtD
Vancomycin—Chills—Etoposide—uterine cancer	0.00263	0.00263	CcSEcCtD
Vancomycin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00261	0.00261	CcSEcCtD
Vancomycin—Vomiting—Progesterone—uterine cancer	0.00259	0.00259	CcSEcCtD
Vancomycin—Rash—Progesterone—uterine cancer	0.00257	0.00257	CcSEcCtD
Vancomycin—Dermatitis—Progesterone—uterine cancer	0.00256	0.00256	CcSEcCtD
Vancomycin—Phlebitis—Doxorubicin—uterine cancer	0.00255	0.00255	CcSEcCtD
Vancomycin—Headache—Progesterone—uterine cancer	0.00255	0.00255	CcSEcCtD
Vancomycin—Thrombophlebitis—Doxorubicin—uterine cancer	0.00254	0.00254	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00252	0.00252	CcSEcCtD
Vancomycin—Renal impairment—Epirubicin—uterine cancer	0.00249	0.00249	CcSEcCtD
Vancomycin—Dermatitis bullous—Epirubicin—uterine cancer	0.00248	0.00248	CcSEcCtD
Vancomycin—Fatigue—Dactinomycin—uterine cancer	0.00248	0.00248	CcSEcCtD
Vancomycin—Back pain—Etoposide—uterine cancer	0.00247	0.00247	CcSEcCtD
Vancomycin—Pain—Dactinomycin—uterine cancer	0.00246	0.00246	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00245	0.00245	CcSEcCtD
Vancomycin—Muscle spasms—Etoposide—uterine cancer	0.00245	0.00245	CcSEcCtD
Vancomycin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00244	CcSEcCtD
Vancomycin—Nausea—Progesterone—uterine cancer	0.00242	0.00242	CcSEcCtD
Vancomycin—Anaemia—Etoposide—uterine cancer	0.00236	0.00236	CcSEcCtD
Vancomycin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00235	0.00235	CcSEcCtD
Vancomycin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00234	CcSEcCtD
Vancomycin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00233	0.00233	CcSEcCtD
Vancomycin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.00233	CcSEcCtD
Vancomycin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00232	CcSEcCtD
Vancomycin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.00231	CcSEcCtD
Vancomycin—Renal impairment—Doxorubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Vancomycin—Dermatitis bullous—Doxorubicin—uterine cancer	0.0023	0.0023	CcSEcCtD
Vancomycin—Vertigo—Etoposide—uterine cancer	0.00229	0.00229	CcSEcCtD
Vancomycin—Abdominal pain—Dactinomycin—uterine cancer	0.00227	0.00227	CcSEcCtD
Vancomycin—Body temperature increased—Dactinomycin—uterine cancer	0.00227	0.00227	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00227	0.00227	CcSEcCtD
Vancomycin—Blood creatinine increased—Epirubicin—uterine cancer	0.00222	0.00222	CcSEcCtD
Vancomycin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00219	CcSEcCtD
Vancomycin—Hypokalaemia—Epirubicin—uterine cancer	0.00216	0.00216	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00216	0.00216	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00214	0.00214	CcSEcCtD
Vancomycin—Hypersensitivity—Dactinomycin—uterine cancer	0.00212	0.00212	CcSEcCtD
Vancomycin—Anaphylactic shock—Etoposide—uterine cancer	0.00208	0.00208	CcSEcCtD
Vancomycin—Infection—Etoposide—uterine cancer	0.00207	0.00207	CcSEcCtD
Vancomycin—Asthenia—Dactinomycin—uterine cancer	0.00206	0.00206	CcSEcCtD
Vancomycin—Blood creatinine increased—Doxorubicin—uterine cancer	0.00206	0.00206	CcSEcCtD
Vancomycin—Thrombocytopenia—Etoposide—uterine cancer	0.00204	0.00204	CcSEcCtD
Vancomycin—Tachycardia—Etoposide—uterine cancer	0.00203	0.00203	CcSEcCtD
Vancomycin—Eosinophilia—Epirubicin—uterine cancer	0.00203	0.00203	CcSEcCtD
Vancomycin—Skin disorder—Etoposide—uterine cancer	0.00202	0.00202	CcSEcCtD
Vancomycin—Hypokalaemia—Doxorubicin—uterine cancer	0.002	0.002	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00198	0.00198	CcSEcCtD
Vancomycin—Hypotension—Etoposide—uterine cancer	0.00195	0.00195	CcSEcCtD
Vancomycin—Neutropenia—Epirubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Vancomycin—Eosinophilia—Doxorubicin—uterine cancer	0.00188	0.00188	CcSEcCtD
Vancomycin—Dyspnoea—Etoposide—uterine cancer	0.00186	0.00186	CcSEcCtD
Vancomycin—Infestation NOS—Epirubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Infestation—Epirubicin—uterine cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Vomiting—Dactinomycin—uterine cancer	0.00183	0.00183	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Rash—Dactinomycin—uterine cancer	0.00181	0.00181	CcSEcCtD
Vancomycin—Renal failure—Epirubicin—uterine cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Etoposide—uterine cancer	0.0018	0.0018	CcSEcCtD
Vancomycin—Fatigue—Etoposide—uterine cancer	0.00179	0.00179	CcSEcCtD
Vancomycin—Pain—Etoposide—uterine cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Constipation—Etoposide—uterine cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Urinary tract infection—Epirubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Neutropenia—Doxorubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Vancomycin—Nausea—Dactinomycin—uterine cancer	0.00171	0.00171	CcSEcCtD
Vancomycin—Agranulocytosis—Epirubicin—uterine cancer	0.00171	0.00171	CcSEcCtD
Vancomycin—Gastrointestinal pain—Etoposide—uterine cancer	0.0017	0.0017	CcSEcCtD
Vancomycin—Infestation NOS—Doxorubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Infestation—Doxorubicin—uterine cancer	0.00169	0.00169	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00168	0.00168	CcSEcCtD
Vancomycin—Bradycardia—Epirubicin—uterine cancer	0.00167	0.00167	CcSEcCtD
Vancomycin—Renal failure—Doxorubicin—uterine cancer	0.00166	0.00166	CcSEcCtD
Vancomycin—Urticaria—Etoposide—uterine cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Body temperature increased—Etoposide—uterine cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Abdominal pain—Etoposide—uterine cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Urinary tract infection—Doxorubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Vancomycin—Oedema peripheral—Epirubicin—uterine cancer	0.00162	0.00162	CcSEcCtD
Vancomycin—Connective tissue disorder—Epirubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Vancomycin—Agranulocytosis—Doxorubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Vancomycin—Erythema multiforme—Epirubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Bradycardia—Doxorubicin—uterine cancer	0.00155	0.00155	CcSEcCtD
Vancomycin—Hypersensitivity—Etoposide—uterine cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Tinnitus—Epirubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Vancomycin—Flushing—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Vancomycin—Oedema peripheral—Doxorubicin—uterine cancer	0.0015	0.0015	CcSEcCtD
Vancomycin—Asthenia—Etoposide—uterine cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Connective tissue disorder—Doxorubicin—uterine cancer	0.00149	0.00149	CcSEcCtD
Vancomycin—Chills—Epirubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Vancomycin—Pruritus—Etoposide—uterine cancer	0.00147	0.00147	CcSEcCtD
Vancomycin—Erythema multiforme—Doxorubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Vancomycin—Erythema—Epirubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Malnutrition—Epirubicin—uterine cancer	0.00143	0.00143	CcSEcCtD
Vancomycin—Tinnitus—Doxorubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Vancomycin—Flushing—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Flatulence—Epirubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Vancomycin—Back pain—Epirubicin—uterine cancer	0.00138	0.00138	CcSEcCtD
Vancomycin—Dizziness—Etoposide—uterine cancer	0.00138	0.00138	CcSEcCtD
Vancomycin—Muscle spasms—Epirubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Vancomycin—Chills—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Vancomycin—Vomiting—Etoposide—uterine cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Erythema—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Malnutrition—Doxorubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Anaemia—Epirubicin—uterine cancer	0.00132	0.00132	CcSEcCtD
Vancomycin—Rash—Etoposide—uterine cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Dermatitis—Etoposide—uterine cancer	0.00131	0.00131	CcSEcCtD
Vancomycin—Headache—Etoposide—uterine cancer	0.0013	0.0013	CcSEcCtD
Vancomycin—Flatulence—Doxorubicin—uterine cancer	0.0013	0.0013	CcSEcCtD
Vancomycin—Vertigo—Epirubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Back pain—Doxorubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Vancomycin—Muscle spasms—Doxorubicin—uterine cancer	0.00127	0.00127	CcSEcCtD
Vancomycin—Palpitations—Epirubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Vancomycin—Nausea—Etoposide—uterine cancer	0.00124	0.00124	CcSEcCtD
Vancomycin—Anaemia—Doxorubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Vancomycin—Vertigo—Doxorubicin—uterine cancer	0.00119	0.00119	CcSEcCtD
Vancomycin—Palpitations—Doxorubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Anaphylactic shock—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Vancomycin—Infection—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Vancomycin—Nervous system disorder—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Thrombocytopenia—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Tachycardia—Epirubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Vancomycin—Skin disorder—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Vancomycin—Hypotension—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Vancomycin—Anaphylactic shock—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Vancomycin—Infection—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Vancomycin—Nervous system disorder—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Thrombocytopenia—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Insomnia—Epirubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Vancomycin—Tachycardia—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Skin disorder—Doxorubicin—uterine cancer	0.00105	0.00105	CcSEcCtD
Vancomycin—Dyspnoea—Epirubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Vancomycin—Hypotension—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Fatigue—Epirubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Vancomycin—Constipation—Epirubicin—uterine cancer	0.000998	0.000998	CcSEcCtD
Vancomycin—Pain—Epirubicin—uterine cancer	0.000998	0.000998	CcSEcCtD
Vancomycin—Insomnia—Doxorubicin—uterine cancer	0.000977	0.000977	CcSEcCtD
Vancomycin—Dyspnoea—Doxorubicin—uterine cancer	0.000963	0.000963	CcSEcCtD
Vancomycin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000954	0.000954	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000932	0.000932	CcSEcCtD
Vancomycin—Fatigue—Doxorubicin—uterine cancer	0.000931	0.000931	CcSEcCtD
Vancomycin—Urticaria—Epirubicin—uterine cancer	0.000927	0.000927	CcSEcCtD
Vancomycin—Pain—Doxorubicin—uterine cancer	0.000923	0.000923	CcSEcCtD
Vancomycin—Constipation—Doxorubicin—uterine cancer	0.000923	0.000923	CcSEcCtD
Vancomycin—Abdominal pain—Epirubicin—uterine cancer	0.000922	0.000922	CcSEcCtD
Vancomycin—Body temperature increased—Epirubicin—uterine cancer	0.000922	0.000922	CcSEcCtD
Vancomycin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000883	0.000883	CcSEcCtD
Vancomycin—Hypersensitivity—Epirubicin—uterine cancer	0.00086	0.00086	CcSEcCtD
Vancomycin—Urticaria—Doxorubicin—uterine cancer	0.000858	0.000858	CcSEcCtD
Vancomycin—Body temperature increased—Doxorubicin—uterine cancer	0.000854	0.000854	CcSEcCtD
Vancomycin—Abdominal pain—Doxorubicin—uterine cancer	0.000854	0.000854	CcSEcCtD
Vancomycin—Asthenia—Epirubicin—uterine cancer	0.000837	0.000837	CcSEcCtD
Vancomycin—Pruritus—Epirubicin—uterine cancer	0.000826	0.000826	CcSEcCtD
Vancomycin—Hypersensitivity—Doxorubicin—uterine cancer	0.000796	0.000796	CcSEcCtD
Vancomycin—Asthenia—Doxorubicin—uterine cancer	0.000775	0.000775	CcSEcCtD
Vancomycin—Dizziness—Epirubicin—uterine cancer	0.000772	0.000772	CcSEcCtD
Vancomycin—Pruritus—Doxorubicin—uterine cancer	0.000764	0.000764	CcSEcCtD
Vancomycin—Vomiting—Epirubicin—uterine cancer	0.000742	0.000742	CcSEcCtD
Vancomycin—Rash—Epirubicin—uterine cancer	0.000736	0.000736	CcSEcCtD
Vancomycin—Dermatitis—Epirubicin—uterine cancer	0.000735	0.000735	CcSEcCtD
Vancomycin—Headache—Epirubicin—uterine cancer	0.000731	0.000731	CcSEcCtD
Vancomycin—Dizziness—Doxorubicin—uterine cancer	0.000714	0.000714	CcSEcCtD
Vancomycin—Nausea—Epirubicin—uterine cancer	0.000693	0.000693	CcSEcCtD
Vancomycin—Vomiting—Doxorubicin—uterine cancer	0.000687	0.000687	CcSEcCtD
Vancomycin—Rash—Doxorubicin—uterine cancer	0.000681	0.000681	CcSEcCtD
Vancomycin—Dermatitis—Doxorubicin—uterine cancer	0.00068	0.00068	CcSEcCtD
Vancomycin—Headache—Doxorubicin—uterine cancer	0.000676	0.000676	CcSEcCtD
Vancomycin—Nausea—Doxorubicin—uterine cancer	0.000641	0.000641	CcSEcCtD
